Expertise in
3
conditions

Dr. Michael M. Tuchman

Neurology
Palm Beach Neurological Center
3355 Burns Rd Ste 201, 
Palm Beach Gardens, FL 
Offers Telehealth
Expertise in
3
conditions
Palm Beach Neurological Center
3355 Burns Rd Ste 201, 
Palm Beach Gardens, FL 

Overview

Michael Tuchman is a Neurologist practicing medicine in Palm Beach Gardens, Florida.

Dr. Tuchman is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Susac Syndrome, Neuralgia, Cerebellar Degeneration, and Peripheral Neuropathy.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 7 clinical trials.

Graduate Institution

University Of Florida College Of Medicine

Specialties

Neurology

Licenses

Psychiatry & Neurology in FL

Hospital Affiliations

Jupiter Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Palm Beach Neurological Center
3355 Burns Rd Ste 201, Palm Beach Gardens, FL 33410

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Enrollment Status: Completed
Publish Date: November 10, 2025
Intervention Type: Drug
Study Drug: ALZ-801
Study Phase: Phase 3
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Enrollment Status: Completed
Publish Date: June 13, 2025
Intervention Type: Drug, Other
Study Drug: Donanemab
Study Phase: Phase 2
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drug: BPN14770
Study Phase: Phase 2
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

9 Total Publications

Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population.
Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population.
Journal: Clinical diabetes and endocrinology
Published: August 23, 2017
Similar Doctors
Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Office

951 NW 13th St Ste 5E, 
Boca Raton, FL 
 (34.5 miles away)
561-392-1818
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stuart Isaacson is a Neurologist practicing medicine in Boca Raton, Florida. Dr. Isaacson is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Orthostatic Hypotension, and Deep Brain Stimulation.

Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required
Before you request

Egil And Pauline Braathen Center/Maroone Cancer Center

2950 Cleveland Clinic Boulevard, 
Weston, FL 
 (55.5 miles away)
877-463-2010
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Imad Najm is a Neurologist practicing medicine in Weston, Florida. Dr. Najm is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Cortical Dysplasia, Generalized Tonic-Clonic Seizure, and Deep Brain Stimulation. Dr. Najm is board certified in American Board Of Psychiatry And Neurology, 2013. Dr. Najm is currently accepting new patients.

Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

Egil And Pauline Braathen Center/Maroone Cancer Center

2950 Cleveland Clinic Boulevard, 
Weston, FL 
 (55.5 miles away)
877-463-2010
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vineet Punia is a Neurologist practicing medicine in Weston, Florida. Dr. Punia is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, and Photosensitive Epilepsy. Dr. Punia is board certified in American Board Of Psychiatry And Neurology, 2016. Dr. Punia is currently accepting new patients.

Frequently Asked Questions about Dr. Michael M. Tuchman

How do I make an appointment with Dr. Michael M. Tuchman?

You can book an appointment with Dr. Michael M. Tuchman by calling their office at 561-694-1010. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael M. Tuchman a top-rated expert for Susac Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael M. Tuchman is classified as an Advanced expert for Susac Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael M. Tuchman specialize in?

While Dr. Michael M. Tuchman is a Neurology, they have specific expertise in Susac Syndrome, Neuralgia, and Cerebellar Degeneration. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Michael M. Tuchman participate in research or clinical trials?

Yes. Dr. Michael M. Tuchman has published 9 articles and abstracts on conditions like Susac Syndrome. You can view a list of Dr. Michael M. Tuchman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael M. Tuchman accept my insurance?

Dr. Michael M. Tuchman accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 561-694-1010 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tuchman's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile